Literature DB >> 35307789

Evolution of treatment in gastric cancer- a systematic review.

Sangram K Panda1, Pradyumna K Sahoo1, Sunil K Agarwala1, Tim Houghton T2, Prathamesh Panchakshari Chandrapattan1, Vikas Sankar K1, Ramkishan Nag1.   

Abstract

Multimodality is the standard of care in gastric cancer but surgery remains the mainstay of curative treatment. As we are heading towards a more conservative approach for functional preservation without compromising oncological outcomes in all malignancies, the guidelines keeps changing based on various studies.The extent of surgery used to vary between the east and west, with the east performing more radical surgery and the west more reliant on multimodality therapy. This practice has been changing in the recent times.In this article we have reviewed how the treatment protocols of gastric cancer has evolved and modified, highlighting the practice changing trials.
© 2022. The Author(s).

Entities:  

Keywords:  Gastric cancer; Multimodality; Treatment; Trials

Mesh:

Year:  2022        PMID: 35307789     DOI: 10.1186/s43046-022-00114-7

Source DB:  PubMed          Journal:  J Egypt Natl Canc Inst        ISSN: 1110-0362


  21 in total

1.  Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Authors:  Chew-Wun Wu; Chao A Hsiung; Su-Shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Anna Fen-Yau Li; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  Lancet Oncol       Date:  2006-04       Impact factor: 41.316

2.  Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial.

Authors:  Yukinori Kurokawa; Yuichiro Doki; Junki Mizusawa; Masanori Terashima; Hitoshi Katai; Takaki Yoshikawa; Yutaka Kimura; Shuji Takiguchi; Yasunori Nishida; Norimasa Fukushima; Yoshiaki Iwasaki; Masahide Kaji; Motohiro Hirao; Hiroshi Katayama; Mitsuru Sasako
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-04-28

3.  Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer.

Authors:  M Degiuli; M Sasako; A Ponti
Journal:  Br J Surg       Date:  2010-05       Impact factor: 6.939

4.  Randomized controlled Phase III trial to evaluate omentum preserving gastrectomy for patients with advanced gastric cancer (JCOG1711, ROAD-GC).

Authors:  Yuya Sato; Takanobu Yamada; Takaki Yoshikawa; Ryunosuke Machida; Junki Mizusawa; Hiroshi Katayama; Masanori Tokunaga; Narikazu Boku; Masanori Terashima
Journal:  Jpn J Clin Oncol       Date:  2020-07-08       Impact factor: 3.019

5.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

6.  Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.

Authors:  Ilfet Songun; Hein Putter; Elma Meershoek-Klein Kranenbarg; Mitsuru Sasako; Cornelis J H van de Velde
Journal:  Lancet Oncol       Date:  2010-04-19       Impact factor: 41.316

7.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

Authors:  Hyuna Sung; Jacques Ferlay; Rebecca L Siegel; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  CA Cancer J Clin       Date:  2021-02-04       Impact factor: 508.702

8.  D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.

Authors:  Mitsuru Sasako; Takeshi Sano; Seiichiro Yamamoto; Yukinori Kurokawa; Atsushi Nashimoto; Akira Kurita; Masahiro Hiratsuka; Toshimasa Tsujinaka; Taira Kinoshita; Kuniyoshi Arai; Yoshitaka Yamamura; Kunio Okajima
Journal:  N Engl J Med       Date:  2008-07-31       Impact factor: 91.245

9.  Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma.

Authors:  Takeshi Sano; Mitsuru Sasako; Junki Mizusawa; Seiichiro Yamamoto; Hitoshi Katai; Takaki Yoshikawa; Atsushi Nashimoto; Seiji Ito; Masahide Kaji; Hiroshi Imamura; Norimasa Fukushima; Kazumasa Fujitani
Journal:  Ann Surg       Date:  2017-02       Impact factor: 12.969

10.  Oncologic Effectiveness and Safety of Bursectomy in Patients with Advanced Gastric Cancer: A Systematic Review and Updated Meta-Analysis.

Authors:  Luigi Marano; Karol Polom; Alberto Bartoli; Alessandro Spaziani; Raffaele De Luca; Laura Lorenzon; Natale Di Martino; Daniele Marrelli; Franco Roviello; Giampaolo Castagnoli
Journal:  J Invest Surg       Date:  2017-10-03       Impact factor: 2.533

View more
  1 in total

1.  Skin metastases from gastric cancer, a rare entity masquerading as erysipelas: A case report.

Authors:  Evangelia Pliakou; Dimitra Ioanna Lampropoulou; Despoina Nasi; Gerasimos Aravantinos
Journal:  Mol Clin Oncol       Date:  2022-05-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.